Episode
Approaching the AI Event Horizon? Part 2, w/ Abhi Mahajan, Helen Toner, Jeremie Harris, @8teAPi
- Published
- Feb 14, 2026
- Duration seconds
- 8579
- Processing state
processed
Actions
POST https://stenobird.com/v1/public/podcasts/the-cognitive-revolution/episodes/approaching-the-ai-event-horizon-part-2-w-abhi-mahajan-helen-toner-jeremie-harris-8teapi/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-cognitive-revolution/approaching-the-ai-event-horizon-part-2-w-abhi-mahajan-helen-toner-jeremie-harris-8teapi.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
An exploration of the strategic and scientific implications of the AI event horizon, focusing on automated R&D and biological breakthroughs. The discussion examines the risks of losing human oversight as AI begins to drive its own development and scientific discovery.
Topics
- Artificial Intelligence
- AI for Science
- Biotechnology
- Geopolitics
- AI Safety
- Automated R&D
- Machine Learning
- Strategic Surprise
Highlights
- Main idea: Automated AI R&D represents a massive source of potential strategic surprise for global powers
- Practical takeaway: AI-driven biology is moving toward foundation models capable of predicting patient-specific cancer treatment responses
- Failure mode: The risk of a 'singularity' where AI systems operate beyond the reach of meaningful human oversight or coordination
- Strategic tension: The difficulty of maintaining US-China coordination in an era of rapid, opaque technological advancement
- Technical trend: A shift toward personalized model training and decentralized ecosystems to prevent big-tech monopolies
Chapters
1:00AI in Biology and Medicine: Abhi Mahajan discusses the potential for foundation models to transform cancer treatment prediction and his skepticism regarding current AI biology literature.12:15The Impact of Advanced Sensing: A look at how improvements in imaging and microscopy act as catalysts for downstream biological AI developments.23:10Regulatory Challenges in AI: Discussion on the alignment between AI development and the regulatory expectations of agencies like the FDA.45:35The Unpredictable Horizon: Reflections on the impossibility of forecasting technological shifts that occur multiple orders of magnitude ahead of current capabilities.56:35The Superhuman Plateau: Analyzing the possibility of AI progress either plateauing at subhuman levels or accelerating into a singularity.1:18:50Geopolitical AI Threat Assessment: Jeremie Harris evaluates the current state of US-China AI competition and the effectiveness of existing threat assessments.1:52:10LLMs as Research Partners: Exploring how large language models can be used to navigate complex technical reasoning and identify conversational blind spots.